Neoplasms, Hormone-Dependent

Publication Title: 
Magyar Onkologia

In several large adjuvant clinical trials it has been demonstrated that substitution (eventually addition) of aromatase inhibitors (AIs) provides an improved outcome of endocrine-sensitive breast cancer over tamoxifen alone. Nevertheless, arthralgia induced by the AIs is one of the most frequent side effects in hormonal therapy. It is characterized by tenosynovial changes and is more frequent in patients in clinical practice than previously appreciated in adjuvant clinical trials.

Author(s): 
Nagykálnai, Tamás
Landherr, László
Mészáros, Edina

Pages

Subscribe to RSS - Neoplasms, Hormone-Dependent